Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-094732
Filing Date
2024-08-09
Accepted
2024-08-09 16:03:47
Documents
64
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q prok-20240630.htm   iXBRL 10-Q 1921996
2 EX-31.1 prok-ex31_1.htm EX-31.1 16515
3 EX-31.2 prok-ex31_2.htm EX-31.2 16497
4 EX-32.1 prok-ex32_1.htm EX-32.1 9436
5 EX-32.2 prok-ex32_2.htm EX-32.2 9449
  Complete submission text file 0000950170-24-094732.txt   8151044

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT prok-20240630.xsd EX-101.SCH 1211008
66 EXTRACTED XBRL INSTANCE DOCUMENT prok-20240630_htm.xml XML 1478703
Mailing Address 2000 FRONTIS PLAZA BLVD. SUITE 250 WINSTON-SALEM NC 27103
Business Address 2000 FRONTIS PLAZA BLVD. SUITE 250 WINSTON-SALEM NC 27103 336-999-7028
PROKIDNEY CORP. (Filer) CIK: 0001850270 (see all company filings)

EIN.: 981586514 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40560 | Film No.: 241192501
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)